Showing results (1-10 of 366) with videos related to

Sort By:
Pageof 37
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2019
[How Should We Design, Conduct, Evaluate, and Apply Clinical Study in a Clinical Setting]Mototsugu Shimokawa, Toshinobu Hayashi
Thoracic Cancer|October 6, 2021
Prognostic impact of chronological age on efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: Real-world data from 86 173 patientsShinkichi Takamori, Mototsugu Shimokawa, Takefumi Komiya
World Journal of Oncology|August 10, 2023
Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung CancerTakefumi Komiya, Shinkichi Takamori, Mototsugu Shimokawa
Journal of Cancer Research and Clinical Oncology|July 21, 2023
Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancerShinkichi Takamori, Mototsugu Shimokawa, Takefumi Komiya
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 30, 2014
Prognostic significance of the treatment-free interval in patients with recurrent endometrial cancerKumi Shimamoto, Toshiaki Saito, Masao Okadome, et al.
General Thoracic and Cardiovascular Surgery|September 30, 2022
Lymph node dissections and survival in sublobar resection of non-small cell lung cancer ≤ 20 mmShinkichi Takamori, Takefumi Komiya, Mototsugu Shimokawa, et al.
Clinical Lung Cancer|February 17, 2024
Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE TrialTaichi Matsubara, Masafumi Yamaguchi, Mototsugu Shimokawa, et al.
Thoracic Cancer|July 22, 2026
Perioperative Aspirin Continuation in Patients Requiring Secondary Prevention Undergoing Anatomical Lung Resection: A Propensity Score-Weighted AnalysisJunichi Murakami, Sota Yoshimine, Mototsugu Shimokawa, et al.
Diabetes, Obesity & Metabolism|January 10, 2018
Tofogliflozin decreases body fat mass and improves peripheral insulin resistanceRen Matsuba, Ikuro Matsuba, Mototsugu Shimokawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 3, 2024
Validation of Japanese indication criteria for deceased donor liver transplantation for hepatocellular carcinoma: Analysis of US national registry dataYuki Bekki, Shinji Itoh, Takeo Toshima, et al.
Pageof 37